These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19722898)

  • 21. Bringing DNA vaccines closer to commercial use.
    Carvalho JA; Prazeres DM; Monteiro GA
    IDrugs; 2009 Oct; 12(10):642-7. PubMed ID: 19790015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.
    Carnes AE; Hodgson CP; Luke JM; Vincent JM; Williams JA
    Biotechnol Bioeng; 2009 Oct; 104(3):505-15. PubMed ID: 19557837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccine design.
    Brandsma JL
    Methods Mol Med; 2006; 127():3-10. PubMed ID: 16988442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process.
    Nelson J; Rodriguez S; Finlayson N; Williams J; Carnes A
    Hum Vaccin Immunother; 2013 Oct; 9(10):2211-5. PubMed ID: 23899469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaling-up recombinant plasmid DNA for clinical trial: current concern, solution and status.
    Ismail R; Allaudin ZN; Lila MA
    Vaccine; 2012 Sep; 30(41):5914-20. PubMed ID: 22406276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal for a better integration of bacterial lysis into the production of plasmid DNA at large scale.
    O'Mahony K; Freitag R; Hilbrig F; Müller P; Schumacher I
    J Biotechnol; 2005 Sep; 119(2):118-32. PubMed ID: 15993505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of supercoiled plasmid.
    Green AP
    Methods Mol Med; 2000; 29():1-9. PubMed ID: 21374304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of large plasmids with methacrylate monolithic columns.
    Krajnc NL; Smrekar F; Cerne J; Raspor P; Modic M; Krgovic D; Strancar A; Podgornik A
    J Sep Sci; 2009 Aug; 32(15-16):2682-90. PubMed ID: 19598166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of RNA clearance in a novel plasmid DNA purification process.
    Murphy JC; Winters MA; Watson MP; Konz JO; Sagar SL
    Biotechnol Prog; 2005; 21(4):1213-9. PubMed ID: 16080704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology.
    Middlebrook JL
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1415-23. PubMed ID: 15896873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks.
    Prazeres DM; Ferreira GN; Monteiro GA; Cooney CL; Cabral JM
    Trends Biotechnol; 1999 Apr; 17(4):169-74. PubMed ID: 10203776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Producing Plasmid DNA Template for Clinical Grade RNA Vaccine Manufacture.
    Shankar R; Schmeer M; Schleef M
    Methods Mol Biol; 2024; 2786():303-319. PubMed ID: 38814401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of plasmid DNA in industrial quantities according to cGMP guidelines.
    Schorr J; Moritz P; Breul A; Scheef M
    Methods Mol Med; 2006; 127():339-50. PubMed ID: 16988464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in chromatographic supports for pharmaceutical-grade plasmid DNA purification.
    Sousa A; Sousa F; Queiroz JA
    J Sep Sci; 2012 Nov; 35(22):3046-58. PubMed ID: 22961759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of PCR technology in vaccine product development.
    Wolf JJ; Wang L; Wang F
    Expert Rev Vaccines; 2007 Aug; 6(4):547-58. PubMed ID: 17669009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical methods for supercoiled pNDA production.
    Ballantyne J
    Methods Mol Med; 2006; 127():311-37. PubMed ID: 16988463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications.
    Ferreira GN; Monteiro GA; Prazeres DM; Cabral JM
    Trends Biotechnol; 2000 Sep; 18(9):380-8. PubMed ID: 10942962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control of biologicals produced by recombinant DNA techniques. WHO consultation.
    WHO Consultation
    Bull World Health Organ; 1983; 61(6):897-911. PubMed ID: 6609009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of plasmids for gene therapy and DNA vaccination.
    Prazeres DM; Monteiro GA; Ferreira GN; Diogo MM; Ribeiro SC; Cabral JM
    Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA manufacturing technology.
    Carnes AE; Williams JA
    Recent Pat Biotechnol; 2007; 1(2):151-66. PubMed ID: 19075838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.